ObsEva SA (OBSV)
Upgrades & Downgrades
Latest OBSV news
ObsEva Announces Presentation of Clinical Data on Oral GnRH Antagonist Linzagolix at ASRM 2021 Scien...
– Presentation of Phase 3 clinical data on linzagolix for the treatment of uterine fibroids and final results from a pilot study of linzagoli x for th...
ObsEva Announces Relationship with Syneos Health to Commercialize Linzagolix
ObsEva Announce s Relationship with Syneos Health to Commercialize Linzagolix
7 Hot Penny Stocks to Buy in Q4 for 10-Bagger Potential
These penny stocks have huge potential and solid business fundamentals. As not-so speculative names, they could surge higher sooner or later.
ObsEva Announces Appointment of Luigi Marro as Chief Transformation Officer
Ad hoc announcement pursuant to Art. 53 LR of the SIX Swiss Exchange
ObsEva (OBSV) Files NDA for Linzagolix to Treat Uterine Fibroids
ObsEva (OBSV) submits an NDA to the FDA for linzagolix as a potential treatment for uterine fibroids.
Zacks Investment Research
ObsEva Announces Submission of New Drug Application to U.S. FDA for Linzagolix for the Treatment of ...
- If approved, linzagolix will be the only GnRH antagonist with flexible dose regimen options to address the clinical needs of more women with uterine...
ObsEva to Present at the H.C. Wainwright 23rd Annual Global Investment Conference
GENEVA, Switzerland September 7 , 202 1 – ObsEva SA (NASDAQ: OBSV; SIX: OBSN), a biopharmaceutical company developing and commercializing novel therap...
5 Penny Stocks To Watch For September With Upcoming Events
These penny stocks could be in focus as we turn the page on a new month. The post 5 Penny Stocks To Watch For September With Upcoming Events appeared ...
7 Hottest Penny Stocks to Pick Up Now
Penny stocks from companies that have reasonable business fundamentals. Stocks that can possibly provide multi-fold returns.